MR Fingerprinting
Quantitative tissue maps enabling improved tissue characterization.

MR Fingerprinting¹
Quantitative tissue maps enabling improved tissue characterization.

Images courtesy: Prof. Siegfried Trattnig, High Field Center, Department for Biomedical Imaging and Image guided Therapy, Medical University of Vienna

Qualitative evaluation of MR images can be inconsistent and may leave many questions:

Hyperintense lesion observed. Indication of disease?
Grade? Infiltration into surrounding tissue?
Prognosis?

MR Fingerprinting facilitates decision making based on digital tissue data. Dedicated MR Fingerprinting acquisition for rapid and robust quantitative T1 and T2 tissue maps of the brain.

Quantification of tissue properties enable robust, reproducible, results - inter-scanner, and in-vivo - for precision medicine.²

Rahmenbedingungen

System

MAGNETOM Prisma
MAGNETOM Prisma^fit
MAGNETOM Skyra
MAGNETOM Vida³
MAGNETOM Vida Fit⁴

Minimum Software Version

syngo MR XA20
syngo MR XA50A (For Vida Fit)

Other

Please Note: Additional technical pre-requisites may apply. Upon receiving your request, your local Siemens representative will clarify whether your system meets the requirements.

Try

Get a Quote Get a Recommendation Subscribe to Newsletter

War diese Information hilfreich für Sie?

syngo MR XA30 and its features are not commercially available in some countries. Due to regulatory reasons their future availability cannot be guaranteed. Please contact your local Siemens organization for further details.

MRF is not for sale in the U.S. Its future availability cannot be guaranteed.

Data on file. Results may vary

MR Fingerprinting for MAGNETOM Vida is pending 510(k) clearance, and is not yet commercially available in the United States. Its future availability cannot be guaranteed.

⁴

MR Fingerprinting for MAGNETOM Vida Fit is still under development and not commercially available yet. Its future availability cannot be ensured.